Stay updated on Inhaled sGC Stimulator in PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled sGC Stimulator in PAH Clinical Trial page.

Latest updates to the Inhaled sGC Stimulator in PAH Clinical Trial page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check22 days agoChange DetectedThe page has been updated to reflect a new version of a clinical study on Frespaciguat (MK-5475) for pulmonary arterial hypertension, with the latest revision dated May 25, 2025, replacing the previous version from February 21, 2025.SummaryDifference15%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check65 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check72 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 21, 2025.SummaryDifference1.0%
Stay in the know with updates to Inhaled sGC Stimulator in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled sGC Stimulator in PAH Clinical Trial page.